Fluorescence-guided surgery with live molecular navigation — a new cutting edge
暂无分享,去创建一个
[1] Vasilis Ntziachristos,et al. Translational optical imaging. , 2012, AJR. American journal of roentgenology.
[2] S. Singletary. Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy. , 2002, American journal of surgery.
[3] Thomas D. Wang,et al. Targeted Imaging of Esophageal Neoplasia with a Fluorescently Labeled Peptide: First-in-Human Results , 2013, Science Translational Medicine.
[4] R Y Tsien,et al. Practical design criteria for a dynamic ratio imaging system. , 1990, Cell calcium.
[5] Hisataka Kobayashi,et al. Fluorescence endoscopic detection of murine colitis-associated colon cancer by topically applied enzymatically rapid-activatable probe , 2012, Gut.
[6] R. Tsien,et al. Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases , 2010, Proceedings of the National Academy of Sciences.
[7] R. Weissleder,et al. Near infrared thoracoscopy of tumoral protease activity for improved detection of peripheral lung cancer , 2006, International journal of cancer.
[8] V. P. Staudinger,et al. Intraoperative Fluorescence Imaging of Peripheral and Central Nerves Through a Myelin-Selective Contrast Agent , 2012, Molecular Imaging and Biology.
[9] N. Rainov,et al. Gamma-Glutamyl Transferase Expression in Higher-grade Astrocytic Glioma , 2001, Acta oncologica.
[10] Rebecca Richards-Kortum,et al. Advances in fluorescence imaging techniques to detect oral cancer and its precursors. , 2010, Future oncology.
[11] Sharmeela Kaushal,et al. Imaging of Primary and Metastatic Pancreatic Cancer Using a Fluorophore-Conjugated Anti-CA19-9 Antibody for Surgical Navigation , 2008, World Journal of Surgery.
[12] M. Soloway,et al. Incidence, etiology, location, prevention and treatment of positive surgical margins after radical prostatectomy for prostate cancer. , 1998, The Journal of urology.
[13] R. Tsien,et al. Improved Facial Nerve Identification with Novel Fluorescently Labeled Probe , 2011, The Laryngoscope.
[14] W. Webb,et al. Multiphoton microscopy and microspectroscopy for diagnostics of inflammatory and neoplastic lung. , 2012, Journal of biomedical optics.
[15] M. Humphreys,et al. Impact of margin status at 37 months after robot assisted radical prostatectomy. , 2011, The Canadian journal of urology.
[16] Beth Friedman,et al. Fluorescent peptides highlight peripheral nerves during surgery in mice , 2011, Nature Biotechnology.
[17] Ryan K. Orosco,et al. Fluorescence Imaging in Surgery , 2013, IEEE Reviews in Biomedical Engineering.
[18] Donghoon Lee,et al. Tumor-targeted drug delivery and MRI contrast enhancement by chlorotoxin-conjugated iron oxide nanoparticles. , 2008, Nanomedicine.
[19] Mark Joseph,et al. Can residents safely and efficiently be taught single incision laparoscopic cholecystectomy? , 2012, Journal of surgical education.
[20] Andrew E. Sloan,et al. Topical Application of Activity-based Probes for Visualization of Brain Tumor Tissue , 2012, PloS one.
[21] R. Snijder,et al. Survival in resected stage I lung cancer with residual tumor at the bronchial resection margin. , 1998, The Annals of thoracic surgery.
[22] Ralph Weissleder,et al. Detection of Invasive Colon Cancer Using a Novel, Targeted, Library-Derived Fluorescent Peptide , 2004, Cancer Research.
[23] Donald L Weaver,et al. Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guideline. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] Georges von Degenfeld,et al. Noninvasive optical imaging of cysteine protease activity using fluorescently quenched activity-based probes. , 2007, Nature chemical biology.
[25] Hisataka Kobayashi,et al. Targeted, activatable, in vivo fluorescence imaging of prostate-specific membrane antigen (PSMA) positive tumors using the quenched humanized J591 antibody-indocyanine green (ICG) conjugate. , 2011, Bioconjugate chemistry.
[26] Paul Steinbach,et al. Real-time in vivo molecular detection of primary tumors and metastases with ratiometric activatable cell-penetrating peptides. , 2013, Cancer research.
[27] H Stepp,et al. Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. , 2000, Journal of neurosurgery.
[28] F. Zanella,et al. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. , 2006, The Lancet. Oncology.
[29] Ralph Weissleder,et al. Improved detection of ovarian cancer metastases by intraoperative quantitative fluorescence protease imaging in a pre-clinical model. , 2009, Gynecologic oncology.
[30] C. Kane,et al. A receptor-targeted fluorescent radiopharmaceutical for multireporter sentinel lymph node imaging. , 2012, Radiology.
[31] R. Pleijhuis,et al. Obtaining Adequate Surgical Margins in Breast-Conserving Therapy for Patients with Early-Stage Breast Cancer: Current Modalities and Future Directions , 2009, Annals of Surgical Oncology.
[32] O. Nativ,et al. Detection of prostate cancer by radio-frequency near-field spectroscopy in radical prostatectomy ex vivo specimens , 2012, Prostate Cancer and Prostatic Diseases.
[33] D. Holmes,et al. Analysis of the Impact of Intraoperative Margin Assessment with Adjunctive Use of MarginProbe versus Standard of Care on Tissue Volume Removed , 2012, International journal of surgical oncology.
[34] Peter L. Choyke,et al. Rapid Cancer Detection by Topically Spraying a γ-Glutamyltranspeptidase–Activated Fluorescent Probe , 2011, Science Translational Medicine.
[35] J. Sandbank,et al. Diagnostic performance of a novel device for real-time margin assessment in lumpectomy specimens. , 2010, The Journal of surgical research.
[36] Miriam Scadeng,et al. Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival , 2010, Proceedings of the National Academy of Sciences.
[37] Hein Putter,et al. Randomized, double-blind comparison of indocyanine green with or without albumin premixing for near-infrared fluorescence imaging of sentinel lymph nodes in breast cancer patients , 2011, Breast Cancer Research and Treatment.
[38] Roger Y Tsien,et al. Systemic in vivo distribution of activatable cell penetrating peptides is superior to that of cell penetrating peptides. , 2009, Integrative biology : quantitative biosciences from nano to macro.
[39] B. Trock,et al. Impact of surgical margin status on prostate‐cancer‐specific mortality , 2012, BJU international.
[40] K. Kavanagh,et al. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival. , 2007, The Journal of urology.
[41] Jae Chul Lee,et al. Learning Curve and Clinical Outcomes of Minimally Invasive Transforaminal Lumbar Interbody Fusion: Our Experience in 86 Consecutive Cases , 2012, Spine.
[42] Phil Quirke,et al. What is the role for the circumferential margin in the modern treatment of rectal cancer? , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[43] John V. Frangioni,et al. Nerve-Highlighting Fluorescent Contrast Agents for Image-Guided Surgery , 2011, Molecular imaging.
[44] Martin Goetz,et al. Confocal Laser Endomicroscopy for Diagnosis and Histomorphologic Imaging of Brain Tumors In Vivo , 2012, PloS one.
[45] Michael Sabel,et al. Comparison of 18F-FET PET and 5-ALA fluorescence in cerebral gliomas , 2011, European Journal of Nuclear Medicine and Molecular Imaging.
[46] N. Rainov,et al. Gamma-Glutamyl Transferase Expression in Higher-grade Astrocytic Glioma , 2001 .
[47] Nina M. Muñoz,et al. Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci. , 2007, Cancer research.
[48] A. Nunn,et al. The Cost of Developing Imaging Agents for Routine Clinical Use , 2006, Investigative radiology.
[49] S. Gambhir,et al. A novel clinically translatable fluorescent nanoparticle for targeted molecular imaging of tumors in living subjects. , 2012, Nano letters.
[50] P. Low,et al. Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results , 2011, Nature Medicine.
[51] 黒田 勝宏. Intra-arterial injection fluorescein videoangiography in aneurysm surgery , 2015 .
[52] M. Talamini,et al. Tumor-specific fluorescence antibody imaging enables accurate staging laparoscopy in an orthotopic model of pancreatic cancer. , 2011, Hepato-gastroenterology.
[53] Donghoon Lee,et al. In vivo MRI detection of gliomas by chlorotoxin-conjugated superparamagnetic nanoprobes. , 2008, Small.
[54] M. Kattan,et al. Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens. , 2005, The Journal of urology.
[55] Roger Y Tsien,et al. In vivo characterization of activatable cell penetrating peptides for targeting protease activity in cancer. , 2009, Integrative biology : quantitative biosciences from nano to macro.
[56] C. V. D. van de Velde,et al. Randomized Comparison of Near-infrared Fluorescence Imaging Using Indocyanine Green and 99m Technetium With or Without Patent Blue for the Sentinel Lymph Node Procedure in Breast Cancer Patients , 2012, Annals of Surgical Oncology.
[57] I. Jatoi,et al. Sentinel Lymph Node Biopsy in Primary Breast Cancer: Window to Management of the Axilla , 2012, World Journal of Surgery.
[58] Alexandros D. Polydorides,et al. Discrimination of Benign and Neoplastic Mucosa with a High-Resolution Microendoscope (HRME) in Head and Neck Cancer , 2012, Annals of Surgical Oncology.
[59] Diana B Petitti,et al. Bmc Ear, Nose and Throat Disorders Open Access Surgical Margins and Survival after Head and Neck Cancer Surgery , 2022 .
[60] P. Low,et al. Folate receptor alpha as a tumor target in epithelial ovarian cancer. , 2008, Gynecologic oncology.
[61] M. Prados,et al. Survival and functional status after resection of recurrent glioblastoma multiforme. , 1998, Neurosurgery.
[62] Ann M Gillenwater,et al. Optical molecular imaging of multiple biomarkers of epithelial neoplasia: epidermal growth factor receptor expression and metabolic activity in oral mucosa. , 2012, Translational oncology.
[63] M. Bogyo,et al. A nonpeptidic cathepsin S activity-based probe for noninvasive optical imaging of tumor-associated macrophages. , 2012, Chemistry & biology.
[64] E. Sevick-Muraca,et al. Comparison of mAbs Targeting Epithelial Cell Adhesion Molecule for the Detection of Prostate Cancer Lymph Node Metastases with Multimodal Contrast Agents: Quantitative Small-Animal PET/CT and NIRF , 2012, The Journal of Nuclear Medicine.
[65] Hak Soo Choi,et al. Simultaneous Assessment of Luminal Integrity and Vascular Perfusion of the Gastrointestinal Tract Using Dual-Channel Near-Infrared Fluorescence , 2012, Molecular imaging.
[66] M. Swierczewska,et al. Dual-functional, receptor-targeted fluorogenic probe for in vivo imaging of extracellular protease expressions. , 2011, Bioconjugate chemistry.
[67] D. Slakey,et al. Robotic transaxillary thyroidectomy: an examination of the first one hundred cases. , 2012, Journal of the American College of Surgeons.
[68] S. Achilefu,et al. Near-infrared fluorescent divalent RGD ligand for integrin αvβ₃-targeted optical imaging. , 2012, Bioorganic & medicinal chemistry letters.
[69] Roger Y Tsien,et al. Tumor imaging by means of proteolytic activation of cell-penetrating peptides. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[70] Vijayashree S. Bhattar,et al. Accuracy of In Vivo Multimodal Optical Imaging for Detection of Oral Neoplasia , 2012, Cancer Prevention Research.
[71] Geoffrey C Gurtner,et al. Intraoperative laser angiography using the SPY system: review of the literature and recommendations for use , 2013, Annals of surgical innovation and research.
[72] H. Kinouchi,et al. Intra-arterial Injection Fluorescein Videoangiography in Aneurysm Surgery , 2013, Neurosurgery.
[73] Merrick I Ross,et al. Positive surgical margins and ipsilateral breast tumor recurrence predict disease‐specific survival after breast‐conserving therapy , 2003, Cancer.
[74] William E Gillanders,et al. Positive margin rates following breast-conserving surgery for stage I-III breast cancer: palpable versus nonpalpable tumors. , 2012, The Journal of surgical research.
[75] James M Olson,et al. In vivo bio-imaging using chlorotoxin-based conjugates. , 2011, Current pharmaceutical design.
[76] M. Panteghini,et al. [Biochemical markers for predicting chemotherapy-induced cardiotoxicity: systematic review of the literature and recommendations for use]. , 2006, Giornale italiano di cardiologia.